Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial
Head & Neck · 2025-12 · 47 (12) · 3301-3309
DOI: 10.1002/hed.28244 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Head & Neck, online erschienen am 15.07.2025. Verfasst von Sarbani Ghosh Laskar und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Enteral Nutrition, Intubation, Gastrointestinal, Chemoradiotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Optimal feeding strategy (Prophylactic vs. Reactive) during Radiation Therapy (RT) for Head and Neck Cancers (HNC) remains to be established.
Methods
This phase III trial randomized (1:1) patients of HNC to prophylactic [nasogastric tube (NGT) placed at least 1 day before RT starting] versus reactive arm (NGT when required). The primary endpoint was the incidence of significant weight loss at 6 months. Secondary endpoints were weight changes, tube duration, dependence, and compliance.
Results
Due to high denial rates, the trial was prematurely closed. Eighty‐four patients (40‐prophylactic, 44‐reactive) were analyzed intention‐to‐treat. Seventeen patients (39%) required a reactive tube insertion. The proportion of patients with significant weight loss at 6 months in the prophylactic versus reactive arms was 13 (32.5%) versus 10 (15.9%), p = 0.44. The median tube duration was 56 days (IQR: 16.5–91) versus 47 days (IQR: 24–59), p = 0.255.
Conclusion
Our limited analysis found that a reactive NGT should be considered for most HNC patients undergoing RT. Trial Registration Clinical trials registry of India: CTRI/2020/01/023049
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
- Department of Clinical Nutrition, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
- Department of Speech and Language Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
- Clinical Research Secretariat, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
- Department of Head and Neck Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
ORCID-Profile: Sarbani Ghosh Laskar, Meenakshi Jeeva, Shiva Thiagarajan
Zitieren
APA
Laskar, S. G., Sinha, S., Jeeva, M., Gupta, M., Karmakar, S., Kumar, A., Mohanty, S., Mahajan, P., Timmanpyati, S., Balaji, A., Budrukkar, A., Swain, M., Khan, F., Pantvaidya, G., Deshmukh, A., Nair, D., Chaukar, D., Pai, P., Thiagarajan, S., …, & Chaturvedi, P. (2025). Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial. Head & Neck, 47(12), 3301-3309. https://doi.org/10.1002/hed.28244
Vancouver
Laskar SG, Sinha S, Jeeva M, Gupta M, Karmakar S, Kumar A, et al. Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial. Head & Neck. 2025;47(12):3301-3309. doi:10.1002/hed.28244
BibTeX
@article{Laskar2025,
author = {Laskar, Sarbani Ghosh and Sinha, Shwetabh and Jeeva, Meenakshi and Gupta, Meetakshi and Karmakar, Shreyasee and Kumar, Anuj and Mohanty, Samarpita and Mahajan, Purabi and Timmanpyati, Shivashankar and Balaji, Arun and Budrukkar, Ashwini and Swain, Monali and Khan, Faizalam and Pantvaidya, Gouri and Deshmukh, Anuja and Nair, Deepa and Chaukar, Devendra and Pai, Prathamesh and Thiagarajan, Shiva and Vaish, Richa and Tuljapurkar, Vidisha and Chaturvedi, Pankaj},
title = {Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial},
journal = {Head & Neck},
year = {2025},
volume = {47},
number = {12},
pages = {3301--3309},
doi = {10.1002/hed.28244}
}
EUVIMED